ZOETIS INC (ZTS) Fundamental Analysis & Valuation

NYSE:ZTS • US98978V1035

Current stock price

121.985 USD
+2.94 (+2.47%)
Last:

This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. ZTS Profitability Analysis

1.1 Basic Checks

  • In the past year ZTS was profitable.
  • ZTS had a positive operating cash flow in the past year.
  • ZTS had positive earnings in each of the past 5 years.
  • In the past 5 years ZTS always reported a positive cash flow from operatings.
ZTS Yearly Net Income VS EBIT VS OCF VS FCFZTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • ZTS has a better Return On Assets (17.28%) than 95.81% of its industry peers.
  • With an excellent Return On Equity value of 80.25%, ZTS belongs to the best of the industry, outperforming 99.48% of the companies in the same industry.
  • ZTS's Return On Invested Capital of 21.95% is amongst the best of the industry. ZTS outperforms 97.38% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ZTS is significantly above the industry average of 13.11%.
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROIC 21.95%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ZTS Yearly ROA, ROE, ROICZTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • ZTS has a better Profit Margin (28.23%) than 93.72% of its industry peers.
  • ZTS's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ZTS (38.54%) is better than 97.38% of its industry peers.
  • ZTS's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ZTS (71.89%) is better than 79.06% of its industry peers.
  • In the last couple of years the Gross Margin of ZTS has remained more or less at the same level.
Industry RankSector Rank
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
ZTS Yearly Profit, Operating, Gross MarginsZTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. ZTS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ZTS is creating value.
  • The number of shares outstanding for ZTS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ZTS has less shares outstanding
  • Compared to 1 year ago, ZTS has a worse debt to assets ratio.
ZTS Yearly Shares OutstandingZTS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ZTS Yearly Total Debt VS Total AssetsZTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ZTS has an Altman-Z score of 5.47. This indicates that ZTS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ZTS (5.47) is better than 72.77% of its industry peers.
  • ZTS has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZTS would need 3.96 years to pay back of all of its debts.
  • The Debt to FCF ratio of ZTS (3.96) is better than 86.39% of its industry peers.
  • ZTS has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • ZTS's Debt to Equity ratio of 2.71 is on the low side compared to the rest of the industry. ZTS is outperformed by 83.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Altman-Z 5.47
ROIC/WACC2.44
WACC8.98%
ZTS Yearly LT Debt VS Equity VS FCFZTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 3.03 indicates that ZTS has no problem at all paying its short term obligations.
  • The Current ratio of ZTS (3.03) is comparable to the rest of the industry.
  • A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.94, ZTS is in line with its industry, outperforming 42.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.03
Quick Ratio 1.94
ZTS Yearly Current Assets VS Current LiabilitesZTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. ZTS Growth Analysis

3.1 Past

  • ZTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.45%, which is quite good.
  • ZTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.77% yearly.
  • Looking at the last year, ZTS shows a small growth in Revenue. The Revenue has grown by 2.28% in the last year.
  • The Revenue has been growing slightly by 7.24% on average over the past years.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.80% on average over the next years.
  • Based on estimates for the next years, ZTS will show a small growth in Revenue. The Revenue will grow by 5.30% on average per year.
EPS Next Y10.17%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
EPS Next 5Y7.8%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZTS Yearly Revenue VS EstimatesZTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ZTS Yearly EPS VS EstimatesZTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

6

4. ZTS Valuation Analysis

4.1 Price/Earnings Ratio

  • ZTS is valuated rather expensively with a Price/Earnings ratio of 19.00.
  • Compared to the rest of the industry, the Price/Earnings ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 84.29% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.53, ZTS is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 17.25 indicates a rather expensive valuation of ZTS.
  • Based on the Price/Forward Earnings ratio, ZTS is valued cheaply inside the industry as 80.63% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 37.95. ZTS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 19
Fwd PE 17.25
ZTS Price Earnings VS Forward Price EarningsZTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZTS is valued cheaper than 82.72% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 84.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.56
EV/EBITDA 13.78
ZTS Per share dataZTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of ZTS may justify a higher PE ratio.
PEG (NY)1.87
PEG (5Y)1.76
EPS Next 2Y8.84%
EPS Next 3Y8.56%

7

5. ZTS Dividend Analysis

5.1 Amount

  • ZTS has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.42, ZTS pays a better dividend. On top of this ZTS pays more dividend than 92.15% of the companies listed in the same industry.
  • ZTS's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of ZTS is nicely growing with an annual growth rate of 20.56%!
  • ZTS has paid a dividend for at least 10 years, which is a reliable track record.
  • ZTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)20.56%
Div Incr Years12
Div Non Decr Years12
ZTS Yearly Dividends per shareZTS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 33.26% of the earnings are spent on dividend by ZTS. This is a low number and sustainable payout ratio.
  • The dividend of ZTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
ZTS Yearly Income VS Free CF VS DividendZTS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
ZTS Dividend Payout.ZTS Dividend Payout, showing the Payout Ratio.ZTS Dividend Payout.PayoutRetained Earnings

ZTS Fundamentals: All Metrics, Ratios and Statistics

ZOETIS INC

NYSE:ZTS (4/17/2026, 2:08:57 PM)

121.985

+2.94 (+2.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners101.23%
Inst Owner Change0.02%
Ins Owners0.07%
Ins Owner Change3.93%
Market Cap51.49B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts76.8
Price Target150.27 (23.19%)
Short Float %3.59%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-20
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-3.34%
PT rev (3m)-7.85%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)3.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 19
Fwd PE 17.25
P/S 5.44
P/FCF 22.56
P/OCF 17.73
P/B 15.46
P/tB N/A
EV/EBITDA 13.78
EPS(TTM)6.42
EY5.26%
EPS(NY)7.07
Fwd EY5.8%
FCF(TTM)5.41
FCFY4.43%
OCF(TTM)6.88
OCFY5.64%
SpS22.43
BVpS7.89
TBVpS-1.03
PEG (NY)1.87
PEG (5Y)1.76
Graham Number33.7616 (-72.32%)
Profitability
Industry RankSector Rank
ROA 17.28%
ROE 80.25%
ROCE 27.58%
ROIC 21.95%
ROICexc 26.6%
ROICexgc 40.59%
OM 38.54%
PM (TTM) 28.23%
GM 71.89%
FCFM 24.12%
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 3.96
Debt/EBITDA 2.19
Cap/Depr 127.52%
Cap/Sales 6.56%
Interest Coverage 13.98
Cash Conversion 70.21%
Profit Quality 85.41%
Current Ratio 3.03
Quick Ratio 1.94
Altman-Z 5.47
F-Score6
WACC8.98%
ROIC/WACC2.44
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.17%
EPS Next 2Y8.84%
EPS Next 3Y8.56%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.61%
EBIT Next 3Y9.66%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%

ZOETIS INC / ZTS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?

ChartMill assigns a fundamental rating of 7 / 10 to ZTS.


Can you provide the valuation status for ZOETIS INC?

ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.


Can you provide the profitability details for ZOETIS INC?

ZOETIS INC (ZTS) has a profitability rating of 9 / 10.


What are the PE and PB ratios of ZOETIS INC (ZTS) stock?

The Price/Earnings (PE) ratio for ZOETIS INC (ZTS) is 19 and the Price/Book (PB) ratio is 15.46.


What is the earnings growth outlook for ZOETIS INC?

The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 10.17% in the next year.